Citizens Maintains Market Outperform on Precigen, Raises Price Target to $11
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Citizens analyst Jason N. Butler maintains Precigen (NASDAQ:PGEN) with a Market Outperform and raises the price target from $9 to $11.
Citizens analyst Jason N. Butler maintains Precigen (NASDAQ:PGEN) with a Market Outperform and raises the price target from $9 to $11.